Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-κB and expression of ICAM-1

Journal of Immunology

Volumn 161, Issue 7, 1998, Pages 3421-3430

  Thommesen, Liv ^a   Sjursen, Wenche ^a   Gåsvik, Kathrine ^a   Hanssen, Wenche ^a   Brekke, Ole Lars ^d   Skattebøl, Lars ^b,c   Holmeide, Anne Kristin ^b,c   Espevik, Terje ^a   Johansen, Berit ^a   Lægreid, Astrid ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Medisinsk Teknisk Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; ENZYME INHIBITOR; FLUOROPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPASE A2; SCALARADIAL; TUMOR NECROSIS FACTOR;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032193215     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.161.7.3421     Document Type: Article

References (12)

1. Fiers, W. 1995. Biological therapy with TNF: preclinical studies. In Biological Therapy of Cancer. 2nd ed. V. T. de Nita, Jr., S. Hellmanna, and S. A. Rosenberg, eds. J. B. Lippincott Company, Philadelphia, p. 295.
2. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotrophic cytokine and therapeutic target. Annu. Rev. Med. 45:491. 266:L722.
3. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
4. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301.
5. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365:182.
6. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773.
7. Laegreid, A., A. Medvedev, U. Nonstad, M. P. Bombara, G. Ranges, A. Sundan, and T. Espevik. 1994. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor κB and induction of human cytomegalovirus enhancer. J. Biol. Chem. 269:7785.
8. Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.
9. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005.
10. Schutze, S., D. Berkovic, O. Tomsing, C. Unger, and M. Kronke. 1991. Tumor necrosis factor induces rapid production of 1′2′diacylglycerol by a phosphatidylcholine-specific phospholipase C. J. Exp. Med. 174:975.
11. Mathias, S., K. A. Dressler, and R. N. Kolesnick. 1991. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:10009.
12. Diaz Meco, M. T., J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat. 1994. Evidence for the in vitro and in vivo interaction of Ras with protein kinase Cζ. J. Biol. Chem. 269:31706.